Resources
Advanced Search
Start Free Trial
Talk With Sales
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Excellergy
Growth Score
87
CB Rank
6496
Heat Score
73
Save
Actions
Excellergy develops immunology-based therapies focused on treating allergic diseases through novel biologic drug candidates.
Acquired by
Novartis
Founded
obfuscated
obfuscation
Private
Series A
Palo Alto
,
California
,
United States
1-10
excellergy.com
Biotechnology
Health Care
Medical
Excellergy
Section: Technology
Actions